National Amphetamine-Type Stimulant Strategy Background Paper: Monograph Series No. 69
Appendix 2
Table of contents
Written submissions
AIDS Council of New South Wales (ACON)
Australian Drug Foundation (ADF)
Australian Government Attorney-General’s Department
Australian Injecting and Illicit Drug Users League
Australian Psychological Society
Convenience Advertising (CONADS)
Drug Free Australia
Drug Arm
Headspace
National Drug and Alcohol Research Centre (NDARC)
National Indigenous Drug and Alcohol Committee
Northern Territory AIDS and Hepatitis Council
Turning Point
Victorian Alcohol and Drug Association
Western Australia Attorney-General’s Department
Western Australia Department of Corrective Services
Youth Substance Abuse Service
Submissions were also received from 5 members of the community
Top of Page
References
AIDS Council of New South Wales. (2006). Crystal. http://www.acon.org.au/health/index.cfm?cat_id=103. AIDS Council of New South Wales.
Ali, R., Baigent, M., Marsden, J., Montiero, M., Srisurapanont, M., Sunga, A., Vial, R., & Wada, K. (2006). WHO Multi-Site Project on Methamphetamine-induced Psychosis: A descriptive report of findings from participating countries. DASSA Research Monograph No. 20. South Australia: Drug & Alcohol Services South Australia.
Allen, B. & Tresidder, J. (2003). Amphetamine type stimulants: An update on the Australian experience. Of Substance, 1 (1), 8-10.
Allsop, S., Addy, D., Ask, A., Vincent, N., & Saunders, C. (1999). From Go to Whoa: The Amphetamine Trainers Package for Health Professionals. A National Dissemination Project. Report submitted to the Commonwealth Department of Health and Ageing. Adelaide: National Centre for Education and Training on Addiction (NCETA).
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Psychiatric Disorders (4th ed., text revision). Washington DC: American Psychiatric Association.
Australian Crime Commission. (2006). Illicit Drug Data Report 2004-05. Canberra: Commonwealth of Australia.
Australian Crime Commission. (2007). Illicit Drug Data Report 2005-06. Canberra: Commonwealth of Australia.
Australian Federal Police. (2007). Annual Report 2005-06. Canberra: Commonwealth of Australia.
Australian Institute of Criminology. (2004). Australian approaches to drug-crime diversion. Crime Reduction Matters, No. 23. Canberra: Australian Institute of Criminology.
Australian Institute of Criminology. (2006). Australian Crime: Facts and Figures. Canberra: Australian Institute of Criminology.
Australian Institute of Criminology. (2007a). Facts and Figures 2006. Canberra: Australian Institute of Criminology.
Australian Institute of Criminology. (2007b). Global seizures of amphetamine-type stimulants. Crime Facts Info, No. 155. Canberra: Australian Institute of Criminology.
Australian Institute of Health and Welfare. (2003). Statistics on drug use in Australia 2002. Drug Statistics Series. Canberra: Australian Institute of Health and Welfare.
Australian Institute of Health and Welfare. (2005a). 2004 National Drug Strategy Household Survey: Detailed Findings. Canberra, Australian Institute of Health and Welfare cat. no. PHE 66. (Drug Statistics Series No. 16).
Australian Institute of Health and Welfare. (2005b). Principal Diagnosis Data Cubes, Separation Statistics by Principal Diagnosis in ICD-10-AM, Australia, 1998-99 to 2003-04, Interactive National Hospital Morbidity Data. Canberra, Australian Institute of Health and Welfare.
Australian Institute of Health and Welfare. (2006a). Alcohol and Other Drug Treatment Services in Australia 2004-05: Report on the National Minimum Data Set. Drug Treatment Series no. 5. Australian Institute of Health and Welfare cat. no. HSE 43. Canberra: Australian Institute of Health and Welfare.
Australian Institute of Health and Welfare. (2006b). Drug use among Aboriginal and Torres Strait Islander peoples: An assessment of data sources. Drug Statistics Series No. 17., cat no. PHE 76. Canberra: Australian Institute of Health and Welfare.
Australian Institute of Health and Welfare. (2007). Statistics on drug use in Australia 2006. Drug Statistics Series. Canberra: Australian Institute of Health and Welfare.
Australian Injecting and Illicit Drug Users League. (2006). A Framework for Peer Education by Drug-User Organisations.
Australian National Council on Drugs. (2006). Drug Use in the Family: Impacts and Implications for Children. Australian National Council on Drugs Research Paper 13. Canberra:
Australian National Council on Drugs.
Australian National Council on Drugs (2007). Methamphetamines: Position Paper. Canberra: Commonwealth of Australia.
Top of Page
Baker, A., Boggs, T.G., & Lewin, T.J. (2001a). Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review, 20, 49-56.
Baker, A., Boggs, T.G., & Lewin, T.J. (2001b). Randomized controlled trial of brief cognitivebehavioural interventions among regular users of amphetamine. Addiction, 96, 1279-1287.
Baker, A., & Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist, 40 (2), 87-94.
Baker, A., & Lee, N.K. (2003). A review of psychosocial interventions for amphetamine use. Drug and Alcohol Review, 22, 323-335.
Baker, A., Lee, N.K., Claire, M., Lewin, T.J., Grant, T., Pohlman, S., Saunders, J.B., Kay-Lambkin, F., Constable, P., Jenner, L., Carr, V.J. (2004). Drug use patterns and mental health of regular amphetamine users during a reported ‘heroin drought’. Addiction, 99 (7), 875-884.
Baker, A., Lee, N.K., Claire, M., Lewin, T.J., Grant, T., Pohlman, S., Saunders, J.B., Kay-Lambkin, F., Constable, P., Jenner, L., & Carr, V.J. (2005). Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction, 100, 367-278.
Baker, A., Lee, N.K., & Jenner, L. (Eds). (2004). Models of intervention and care for psychostimulant users (2nd Edition). National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
Baker, A., Kay-Lambkin, F., Lee, N.K., Claire, M. & Jenner, L.. (2003). A Brief Cognitive Behavioural Intervention for Regular Amphetamine Users. Canberra: Australian Government Department of Health and Ageing.
Bakken, K., Landheim, A.S., & Vaglum, P. (2003). Primary and secondary substance misusers:Do they differ in substance-induced and substance independent mental disorders? Alcohol & Alcoholism, 38, 54-59.
Barr, A.M., Panenka, W.J., MacEwan, W., Thornton, A.E., Lang, D.J., Honer, W.G., & Lecomte, T. (2006). The need for speed: An update on methamphetamine addiction. Journal of Psychiatry and Neuroscience, 31 (5), 301-313.
Battjes, R.J., Leukefeld, C.G. & Pickens, R.W. (1992). Age at first injection and HIV risk among intravenous drug users. American Journal of Drug and Alcohol Abuse, 18 (3), 263-273.
Baumann, M.H., Wang, X. & Rothman, R.B. (2007). 3,4 Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: A reappraisal of past and present findings. Psychopharmacology, 189, 407-424.
Beck, A.T., Steer, R.A., & Brown, G.K. (1996). Beck Depression Inventory (2nd Ed). New York: Psychological Corporation.
Bell, J. (2006). The facts behind amphetamines. InPharmation, 7 (1), 6-11.
Bellis, M.A., Hughes, K., & Lowey, H. (2002). Healthy nightclubs and recreational substance use: From a harm minimisation to a healthy settings approach. Addictive Behaviors, 27, 10251035.
Benschop, A., Rabes, M., & Korf, D. J. (2002). Pill testing, ecstasy and prevention. A scientific evaluation in three European cities. Amsterdam: Rozenberg Publishers.
Berg, R. (1994). Impact Evaluation of the “Speed Wise Speed Safe” Campaign. Paper prepared for the Drug and Alcohol Directorate, New South Wales Department of Health.
Bertram, S., Barbir, N., Ball, J. & Carroll, T. (2003). National Illicit Drugs Campaign: Evaluation of Phase One.http://drugs.health.gov.au/internet/drugs/publishing.nsf/Content/home
Black, E., Degenhardt, L. & Stafford, J. (2005). NSW Drug Trends 2005: Findings from the Illicit Drug Reporting System. National Drug and Alcohol Research Centre. Sydney, University of New South Wales.
Black, E., Dolan, K. & Wodak, A. (2004). Supply, demand and harm reduction strategies in Australian prisons. Report prepared for the Australian National Council; on Drugs. National Drug and Alcohol centre Sydney: New South Wales.
Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. Lancet, 365, 12171218.
Boot, B.P., McGregor, I.S., & Hall, W. (2000). MDMA (Ecstasy) neurotoxicity: Assessing and communicating the risks. Lancet, 355, 1818-1821.
Borzyck, M. (2005). Interventions for Prisoners Returning to the Community. Canberra: Attorney General’s Department.
Botvin, G. J. & Griffin, K. W. (2003). Drug abuse prevention curricula in schools. In Z. Sloboda & W. J. Bukoski (Eds), Handbook of Drug Abuse Prevention. Theory Science and Practice (pp. 45-74). Kluwer Academic/Plenum Publishers: New York.
Bowers, J. & Johnson, S. (2003). Measuring the geographical displacement and diffusion of benefit effects of crime prevention activity. Journal of Quantitative Criminology, 19 (3), 275-301.
Boys, A., Marsden, J., Griffiths, P., Fountain, J., Stilwell, G. & Strang, J. (1999). Substance uses among young people: The relationship between perceived functions and intentions. Addiction, 94 (7), 1042-1050.
Bradbeer, T.M., Fleming, P.M., Charlton, P., & Crichton, J.S. (1998). Survey of amphetamine prescribing in England and Wales. Drug and Alcohol Review, 17, 299-304.
Braga A. (2005). Hot spots policing and crime prevention: a systematic review of randomized controlled trials. Journal of Experimental Criminology, 1 (3), 317-342.
Brauer, L.H. & De Wit, H. (1997). High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacology Biochemistry and Behavior, 56 (2), 265-272.
Brookhuis, K.A.,de Waard, D., & Samyn, N. (2004). Effects of MDMA (ecstasy), and multiple drug use on (simulated) driving performance and traffic safety. Psychopharmacology, 173 (3-4), 440-445.
Brown, P., Wise, R., & Kiyatkin, E. (2003). Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. Journal of Neuroscience, 23, 3924-3929.
Burns, L., Mattick, R. & Cooke, M. (2006). Use of record linkage to examine illicit drug use in pregnancy. Addiction, 10 (6), 873-882.
Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68, 299-307.
Butler, T., Andrews, G., Allnutt, S., Sakashita, C., Smith, N.E., & Basson, J. (2006). Mental disorders in Australian prisoners: A comparison with a community sample. Australian and New Zealand Journal of Psychiatry, 40, 272-276.
Buxton, N. & McConachie, N.S. (2000). Amphetamine abuse and intracranial haemorrhage. Journal of the Royal Society of Medicine, 93 (9), 472-477.
Bywood, P., Pidd, K. & Roche, A. (2006). Information and Data Sheet 5: Illicit drugs in the Australian workforce: Prevalence and patterns of use, Workplace Drug and Alcohol Use Information and Data Series. Adelaide, South Australia: National Centre for Education and Training on Addiction, Flinders University.
Top of Page
Caldicott, D.G.E., Beattie, R., & Edwards, J.W. (2005). Clandestine drug laboratories in Australia and the potential for harm. Australian and New Zealand Journal of Public Health, 29, 155162.
Camilleri, A. M., & Caldicott, D. (2005). Underground pill testing, down under. Forensic Science International, 151(1), 53-58.
Cantwell, B. & McBride, A.J. (1998). Self detoxification by amphetamine dependent patients: A pilot study. Drug and Alcohol Dependence, 49 (2), 157-163.
Carcach, C & Makkai, T, (2001). Review of Victoria Police Statistics, Research and Public Policy Series. Canberra: Australian Institute of Criminology.
Carnwath, T., Garvey, T. & Holland, J.J. (2002). The prescription of dexamphetamine to patients with schizophrenia and amphetamine dependence. Journal of Psychopharmacology, 16(4), 373-377.
Chaiken J., & Chaiken, M. (1990). Drugs and predatory crime. I M. Tonry & J. Wilson (Eds), Drugs and Crime. Chicago: University of Chicago Press.
Chang, L., Cloak, C., Patterson, K. Grob, C., Miller, E.N. & Ernst, T. (2005). Enlarged striatum
in abstinent methamphetamine abusers: A possible compensatory response. Biological Psychiatry, 57, 967-974.
Chawla, S. (1998). ‘They’re synthetic. They’re clandestine. They can heal. They can kill.’ UN Chronicle, 25 (2), 34-36.
Chen, C.K., Lin, S.K., Sham, P.C., Ball, S.D., Loh, E.W., Hsiao, C.C., Chiang, Y.L., Ree,
S.C., Lee, C.H., & Murray, R.M. (2003). Pre-morbid characteristics and co-morbidity of
methamphetamine users with and without psychosis. Psychological Medicine, 33, 14071414.
Cherney, A., Juani O’Reilly, J., & Grabosky, P. (2006). The multilateralization of policing: The case of illicit synthetic drug control. Police Practice and Research, 7 (3), 17 -194.
Chilvers, M., Korabelnikoff, V. & Ramsay, M. (2002). Recent trends in recorded crime and police activity in Cabramatta. Crime and Justice Bulletin, 7 May 2002.
Cohen, R.S. (1998). The Love Drug: Marching to the Beat of Ecstasy. New York: Haworth Medical Press.
Clemens, K.J., van Nieuwenhuyzen, P.S., Li, K.M., Cornish, J.L., Hunt, G.E., & McGregor, I.S.
(2004). MDMA (“Ecstasy”), methamphetamine and their combination: Long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology, 173, 318-325.
Clemens, K.J., McGregor, I.S., Hunt, G.E. & Cornish, J.L. (2007). MDMA, methamphetamine and their combination: Possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review, 26, 9-15.
Collins, M., Dyer, K., & Fox, A. (unpublished). Neurocognitive profiles of amphetamine and alcohol dependent patients in an outpatient clinic.
Conroy, A. (2006). An overview of mental health issues in a large community sample of amphetamine users in Queensland. Paper presented at the Australasian Amphetamines Conference; Sydney: Australia.
Coupland, H., Ball, K., Costello, M., Harvey, B., & Maher, L. (2005). “Something is Going to Get Us: A Consultation and Development project for a National Campaign Addressing Injecting Drug Use in Indigenous Communities. AIVL.
Crits-Christoph, P., Siqueland, L., Blaine, J., Frank, A., Lubursky, L., Onken, L.S., Muenz, L.R., Thase, M.E., Weiss, R.D., Gastfriend, D.R., Woody, G.E., Barber, J.P., Butler., S.F., Daley,
D., Salloum, I., Bishop, S., Najavits, L.M., Lis, J., Mercer, D., Griffin, M.L., Moras, K. &
Beck, A. (1999). Psychosocial treatments for cocaine dependence. Archives of General Psychiatry, 56(6), 493-502.
Croft, R.J., Mackay, A.J., Mills, A.T., & Gruzelier, J.G. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology Bulletin, 153 (3).
Cruickshank, C.C., Montebello, M.E., Dyer, K.R., Quigley, A., Blaszczyk, J., Tomkins, S., & Shand, D. (unpublished). A placebo-controlled trial of mirtazepine and narrative therapy for the management of methamphetamine withdrawal.
Cunningham, J.K. & Liu, Lon-Mu. (2005).Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction, 100, 479-488.
Curran, H.V. (2000). Is MDMA (‘Ecstasy’) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology, 42: 34-41.
Top of Page
Darke, S., Cohen, J., Ross, J., Hando, J., & Hall, W. (1994). Transitions between routes of administration of regular amphetamine users. Addiction, 89, 1077-1083.
Darke, S., Ross, J., Hando, J., Hall, W., & Degenhardt, L. (2000). Illicit Drug Use in Australia: Epidemiology, Use Patterns and Associated Harm. National Drug Strategy Monograph
Series No. 43. Canberra: Commonwealth Department of Health and Aged Care.
Davey, J., Davies, A., French, N., Williams, C.K. & Lang, C.P. (2005). Drug driving from a user’s perspective. Drugs: Education, Prevention and Policy, 12, 61-70.
Davidson, C., Gow, A.J., Lee, T.H., & Ellinwood, E.H. (2001). Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research Reviews, 36 (1), 1-22.
Dawe, S., & McKetin, R. (2004). The psychiatric comorbidity of psychostimulant use. In A.Baker, N.K. Lee, & L.Jenner (Eds.), Towards Better Interventions and Care for Psychostimulant Users (2nd ed., pp. 154-168). Canberra: Commonwealth of Australia.
Dean, A. (2004). Pharmacology of psychostimulants. In A. Baker, N.K. Lee, & L. Jenner (Eds), Models of Intervention and Care for Psychostimulant Users (2nd Edition). National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
Dean, A., & McGuire, T. (2004). Psychostimulant use in pregnancy and lactation. In A. Baker, N.K. Lee, & L. Jenner (Eds), Models of Intervention and Care for Psychostimulant Users (2nd Edition). National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
Degenhardt, L. (2005). Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference? Culture, Health & Sexuality, 7 (6), 599-614.
Degenhardt, L., Coffey, C., Carlin, J.B., Moran, P., & Patton, G.C. (2007a). Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction, 102, 1269-1279.
Degenhardt, L., Coffey, C., Moran, P., Carlin, J.B., & Patton, G.C. (2007b). The predictors and consequences of adolescent amphetamine use: Findings from the Victoria Adolescent Health Cohort Study. Addiction, 102, 1076-1084.
Degenhardt, L., McGuigan, D., & Clayton, S. (2005). Rapid assessment of crystal methamphetamine and GHB use in the gay, lesbian and transgender community in New South Wales. Technical Report No. 235. Sydney: National Drug and Alcohol Research Centre.
Degenhardt, L. & Roxburgh, A. (2007). 2005 Cocaine and Methamphetamine Related Drug-induced Deaths in Australia. Sydney: National Drug and Alcohol Research Centre.
Degenhardt, L., Roxburgh, A., & McKetin, R. (2007). Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Medical Journal of Australia, 186 (7), 342-345.
Degenhardt, L. & Topp, L. (2003). Crystal methamphetamine use among polydrug users in Sydney’s dance party subculture: Characteristics, use patterns and associated harms. International Journal of Drug Policy, 14, 1. 17.
Delahunty, B. & Putt, J. (2006). The policing implications of cannabis, amphetamine and other illicit drug use in Aboriginal and Torres Strait Islander communities. National Drug Law Enforcement Research Fund Monograph Series No. 15. Canberra: Commonwealth of Australia.
Department of Health and Ageing. (1999). Illicit Drug Diversion Initiative—National Principles. Commonwealth Government of Australia.
Dewey, S., Schiffer, W., Lee, D., Kothari, S., Aquilina, S., Mullapudi, U. (2006). S-(+)-Gamma vinyl-GABA (S-GVG) blocks methamphetamine-induced increases in brain dopamine and 18FDG uptake in adolescent animals as well as the metabolic response to methamphetamine as adults. Journal of Nuclear Medicine, 47, 11P.
Dillon, P. (2000). 10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do? http://www.clubhealth.org.uk/pages/2000/p2_p4.htm.
Doak, P. (2001). New South Wales Recorded Crime Statistics 2000. Sydney: NSW BOCSAR.
Dobinson, I. & Ward P. (1985). Drugs and Crime: A survey of NSW Prison Property Offenders. Sydney: NSW BOCSAR.
Donovan, D.M., & Wells, E.A. (2007). ‘Tweaking 12-Step’: The potential role of 12-Step self-help group involvement in methamphetamine recovery. Addiction, 102 (Suppl 1), 121-129.
Donovan, S.J. & Nunes, E.V. (1998). Treatment of comorbid affective and substance use disorders: Therapeutic potential of anticonvulsants. American Journal on Addictions, 7 (3), 210-220.
Dowsett, G.W., Turney, L., Woodcock, G., Rance, A., & Thomson, N. (1999). Hepatitis C prevention education for injecting drug users in Australia. Melbourne: Australian Research Centre in Sex, Health and Society, La Trobe University.
Drug & Alcohol Services South Australia and South Australia Police. (2006). Guidelines for Safer Dance Parties. Adelaide: Government of South Australia.
Drugs and Crime Prevention Committee. (2004). Inquiry into Amphetamine and ‘Party Drug’ Use in Victoria: Final Report. Melbourne: Drugs and Crime Prevention Committee.
Drummer, O.H., Gerostamoulous, J., Batziris, H., Chu, M., Caplehorn, J.R.M., Robertson, M.D.,
& Swann, P. (2003). The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Science International, 134, 154-162.
Duff, C., Johnston, J., Moore, D., & Goren, N. (2007). Dropping, Connecting, Playing and Partying: Exploring the Social and Cultural Contexts of Ecstasy and Related Drug Use in Victoria. Melbourne: Department of Human Services, Victoria.
Dundes, L. (2003). DanceSafe and ecstasy: protection or promotion? Journal of Health and Social Policy, 17, 19-37
Dunlop, A. & Tulloch. (2007). Stimulant treatment program: Newcastle update. Presentation at Winter School, Brisbane.
Dunn, M., Degenhardt, L., Campbell, G., George, J., Johnston, J., Kinner, S., Matthews, A., Newman, J., & White, N. (2007). Australian Trends in Ecstasy and Related Drug Markets 2006: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Dyer, K.R., & Cruickshank, C.C. (2005). Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome. Australian Psychologist, 40 (2), 96-108.
Top of Page
Eggert, L., Thompson, E., Herting, J., Nicholas, L. & Dicker, B. (1994). Preventing adolescent drug abuse and high school dropout through an intensive school-based social network development program. American Journal of Health Promotion, 8(3), 202-215.
European Monitoring Centre for Drugs and Drug Addiction. (2001). On-site pill testing interventions in the European Union. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
Enlighten. (2005). http://www.enlighten-hr.org/testingkits.php. Retrieved 13 December 2005.
Feeney, G.F.X., Connor, J.P., Young, R.McD., Tucker, J., & McPherson, A. (2006). Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addictive Behaviors, 31 (10), 1833-1843.
Fennema, J.S.A., van Ameijden, E.J.C., van den Hoek, A. & Coutinho, R.A. (1997). Young and recent-onset injecting drug users are at higher risk for HIV. Addiction, 92 (11), 1457-1465.
Fetherston, J & Lenton, S. (2007). WA Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Technical Report No. 268. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Fleming, P.M. (1998). Prescribing amphetamine to amphetamine users as a harm reduction measure. International Journal of Drug Policy, 9, 339-344.
Foerster, A., Lewis, S., Owen, M., & Murray, R. (1991). Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis. British Journal of Psychiatry, 158, 171-176.
Fowler, G., Kinner, S.A., & Krenske, L. (in press). Containing ecstasy: Analytical tools for profiling
an illegal drug market. NDLERF Monograph.
Furr, C.D., Delva, J., & Anthony, J.C. (2000). The suspected association between methamphetamine (“ice”) smoking an frequent episodes of alcohol intoxication: Data from the 1993 National Household Survey on Drug Abuse. Drug and Alcohol Dependence, 59, 89-93.
Gonsalves, V.M., Sapp, J.L., & Huss, M.T. (2007). A comparison of methamphetamine and nonmethamphetamine users in a dual diagnosis facility. Addiction Research and Theory, 15 (3), 277-284.
Gossop, M., Griffiths, P., & Strang, J. (1988). Chasing the dragon: Characteristics of heroin chasers. British Journal of Addiction, 83, 1159-1162.
Gowing, L., Henry-Edwards, S., Irving, R., & Ali, R. (2001). Ecstasy: MDMA and other ring-substituted amphetamines. Produced for the World Health Organisation by Drugs and Alcohol Services Council (DASC); Adelaide: South Australia.
Gowing, L.R., Henry-Edwards, S.M., Irvine, R.J., & Ali, R.L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21 (1), 53-63.
Grabowski, J., Shearer, J., Merrill, S., & Negus, S. (2004). Agonist-like, replacement and pharmacotherapy for stimulant abuse and dependence. Addictive Behaviours, 29, 14391464.
Gray, S.D., Fatovich, D.M., McCoubrie, D.L., Daly, F.F. (2007). Amphetamine related presentations to an inner-city tertiary emergency department: A prospective evaluation. Medical Journal of Australia, 186, 336-339.
Green, L (1996). Policing Places with Drug Problems. Thousand Oaks: Sage Publications.
Griggs, W., Caldicott, D., Pfeiffer, J., Edwards, N., Pearce, A. & Davey, M. (2007). The impact of drugs on road crashes, assaults and other trauma – a prospective trauma toxicology study. National Drug Law Enforcement Research Fund (NDLERF) Monograph Series No. 20. Commonwealth of Australia.
Gruenert, S., Ratnam, S., & Tsantefski, M. (2004). The Nobody’s Clients Project: Identifying and Addressing the Needs of Children with Substance Dependent Parents. Victoria: Odyssey Institute of Studies, Odyssey House.
Guillot, C., & Greenway, D. (2006). Recreational ecstasy use and depression. Journal of Psychopharmacology, 20 (3), 411-416.
Gutchewsky, C. (2003). Methamphetamine and Child Welfare. Council Blufds, IA: Iowa Department of Human Services.
Top of Page
Halkitis, P.N., Parsons, J.T., & Stirratt, M.J. (2001). A double epidemic: Crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41, 17-35.
Hall, W., Darke, S., Ross, M. & Wodak, A. (1993). Patterns of drug use and risk-taking among injecting amphetamine and opioid users in Sydney, Australia. Addiction, 88(4), 509-516.
Hall, W., Hando, J., Darke, S., & Ross, J. (1996). Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction, 91, 81-87.
Haller, J., Makara, G.B., & Kruk, M.R. (1998). Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic, and central noradrenergic systems. Neurosciences and Biobehavioral Reviews, 22, 85-97.
Hammersley, R., Khan, F., & Ditton, J. (2002). Ecstasy and the Rise of the Chemical Generation. London and New York: Routledge.
Hando, J. & Hall, W. (1997). Patterns of amphetamine use in Australia. In H. Klee (Ed.), Amphetamine Misuse: International Perspectives on Current Trends. The Netherlands: Harwood Academic Publishers.
Hando, J., Hall, W., Rutter, S. & Dolan, K. (1999). Current State of Research on Illicit Drugs in Australia. Canberra: NH&MRC.
Hando, J., Topp, L. & Dillon, P. (1998). Ecstasy use in Sydney II: Associated harms and risk taking behaviour. In P.Dillon, L.Topp & W.Swift (Eds.), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium. Sydney: National Drug and Alcohol Research Centre.
Hando, J., Topp, L. & Hall, W. (1997). Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence, 46, 105-113.
Harris, C. (2007). Drugs and Alcohol in the Workplace. Australian Chamber of Commerce and Industry. Issues Paper.
Hatzipetros, T., Raudensky, J.G., Soghomonian, J., & Yamamoto, B.K. (2007). Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata. Journal of Neuroscience, 27 (22), 5895-5902.
Hawke, J.M., Jainchill, N. & de Leon, G. (2000). Adolescent amphetamine users in treatment: Client profiles and treatment outcomes. Journal of Psychoactive Drugs, 32 (1), 95-105.
Heffernan, E.B. (2006). Methamphetamines and mental illness. Presentation at Australasian Amphetamine Conference: Sydney, Australia.
Heffernan, E.B., Finn, J., Saunders, J.B., & Byrne, G. (2003). Substance-use disorders and psychological distress among police detainees. Medical Journal of Australia, 179, 408411.
Hegadoren, K.M., Baker, G.B., & Bourin, M. (1999). 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neuroscience Biobehavioural Review, 23, 539-553.
Henry-Edwards, S. (2001). Psychostimulants in Australia. Unpublished paper prepared on behalf of the National Expert Advisory Committee on Illicit Drugs.
Herman-Stahl, M.A., Krebs, C.P., Kroutil, L.A. & Heller, D.C. (2007). Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addictive Behaviors, 32, 1003-1015.
Hillhouse, M.P., Marinelli-Casey, P., Gonzales, R., Ang, A., Rawson, R.A. and the Methamphetamine Treatment Project Corporate Authors. (2007). Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction, 102 (Suppl. 1), 84-95.
Hillier, L., de Visser, R., Kavanagh, A. & McNair, R. (2003). The association between licit and illicit drug use and sexuality in young Australian women. Medical Journal of Australia, 179(6), 326-327.
Hillier, L., Turner, A. & Mitchell, A. (2005). Writing themselves in again - six years on: the second national report on the sexuality, health and well-being of same sex attracted young people. Melbourne: Australian Research Centre in Sex Health and Society, La Trobe University.
Homel, P. & Willis, K. (2007) A framework for measuring the performance of drug law enforcement. Trends and Issues in Crime and Criminal Justice, No. 332. Canberra: Australian Institute of Criminology.
Horton, D.K., Berkowitz, Z., & Kaye, W.E. (2003). The acute health consequences to children exposed to hazardous substances used in illicit methamphetamine production. 1996 2001. Journal of Child Health, 1, 99-108.
Hser, Y., Evans, E., Huang, Y.C. (2005). Treatment outcomes among women and men methamphetamine abusers in California. Journal Substance Abuse Treatment, 28, 77-85.
Hull, P., Brown, G., Rawstorne, P., Prestage, G., Kippax, S. & Langdon, T. (2005). Gay community Periodic Survey Perth 2004. National Centre in HIV Social Research, National Centre in HIV Epidemiology and Clinical Research, Western Australian Centre for Health Promotion Research and Western Australia AIDS Council, National Centre in HIV Social Research.
Hull, P., Prestage, G., Rawstorne, P., Kippax, S., Horn, G., Kennedy, M., Hussey, G. & Batrouney, C. (2006). Gay community Periodic Survey Melbourne 2005. National Centre in HIV Social Research, National Centre in HIV Epidemiology and Clinical Research and Victorian AIDS Council/Gay Men’s Health Centre, National Centre in HIV Social Research.
Hull, P., Rawstorne, P., Prestage, G., Crawford, J., Kippax, S., Sutherland, R., McGuigan, D. & Honnor, G. (2006a). Sydney Gay Community Periodic Survey February 1996 to August 2005. National Centre in HIV Social Research, National Centre in HIV Epidemiology and Clinical Research and The University of New South Wales, National Centre in HIV Social Research.
Hull, P., Rawstorne, P., Zablotska, I., Prestage, G., Kippax, S., Staunton, S., Harrison, G., Hakala, T., Martin, P. & O’Connor, S. (2006b). Gay Community Periodic Survey Queensland 2005. National Centre in HIV Social Research, National Centre in HIV Epidemiology and Clinical Research, Queensland AIDS Council and Queensland Positive People, National Centre in HIV Social Research.
Hung, M.J., Kuo, L.T. & Cherng, W.J. (2003). Amphetamine-related acute myocardial infarction due to coronary artery spasm. International Journal of Clinical Practice, 57 (1), 62-64.
Top of Page
Inciardi, J. & McElgrath, K. (1995). The American Drug Scene: An Anthology. Los Angeles CA: Roxbury Publishing Co.
International Union of Pure and Applied Chemistry. (1993). A Guide to IUPAC Nomenclature of Organic Compounds. New York: Blackwell Scientific Publication.
Irvine, G.D. & Chin, L. (1991). The environmental impact and adverse effects of the clandestine manufacture of methamphetamine. Methamphetamine Abuse, Epidemiological Issues and Implications, Research Monograph 115. National Institute on Drug Abuse.
Iversen, J., Topp, L., Maher, L., Degenhardt, L., O’Brien, S. & Black, E. (2006). Drug use trends among injecting drug users: Findings from the Australian Needle and Syringe Program Survey, 2001–2005. IDRS Drug Trends Bulletin, October 2006. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Jenner, L., Baker, A., Whyte, I., & Carr, V. (2004a). Management of patients with psychostimulant use problems - guidelines for general practitioners. Canberra: Australian Government Department of Health and Ageing.
Jenner, L., Baker, A., Whyte, I., & Carr, V. (2004b). Psychostimulants –Management of acute behavioural disturbances. Guidelines for police services. Canberra: Australian Government Department of Health and Ageing.
Jenner, L., Spain, D., Whyte, I., Baker, A., Carr, V.J., & Crilly, J. (2006a). Management of patients with psychostimulant toxicity: guidelines for ambulance services. Canberra: Australian Government Department of Health and Ageing.
Jenner, L., Spain, D., Whyte, I., Baker, A., Carr, V.J., & Crilly, J. (2006b). Management of patients with psychostimulant toxicity: guidelines for emergency departments. Canberra: Australian Government Department of Health and Ageing.
Johnson, D. (2001). Age of illicit drug initiation. Trends and Issues in Crime and Criminal Justice, No 201. Canberra: Australian Institute of Criminology.
Johnson, H. (2004). Key findings from the drug use careers of female offenders study. Trends & Issues in Crime and Criminal Justice, No. 289. Canberra: Australian Institute of Criminology.
Johnston, J., Barratt, M.J., Fry, C.L., Kinner, S., Stoove, M., Degenhardt, L., George, J.,
Jenkinson, R., Dunn, M, & Bruno, R. (2006). A survey of regular ‘ecstasy’ users’
knowledge and practices around determining pill content and purity: Implications for policy and practice. International Journal of Drug Policy, 17 (6), 464 – 472.
Kalant, H. (2001). The pharmacology and toxicology of ‘ecstasy’ (MDMA) and related drugs. Canadian Medical Association Journal, 165 (7), 917-928.
Kalechstein, A., Newton, T., & Green, M. (2003). Methamphetamine dependence is associated
with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 215-220.
Kamieniecki, G., Vincent, N., Allsop, S., & Lintzeris, N. (1998). Models of Intervention and Care for Psychostimulant Users. Monograph Series No. 32. NCETA.
Kelly, E., McKetin, R., & McLaren, J. (2005). Health service utilisation among regular amphetamine users. Sydney: National Drug and Alcohol Research Centre.
Kema, I.P., de Vries, E.G., & Muskiet, F.A. (2000). Clinical chemistry of serotonin and metabolites. Journal of Chromatography B-Biomedical Applications, 747 (1-2), 33-48.
Kessler, R.C., Andrews, G., Colpe, L.J., Hiripi, E., Mroczek, D.K., Normand, S-L.T., Walters, E.E., & Zaslavsky, A.M. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine, 32, 959-976.
Kingswell, B. (2007). Amphetamine Psychosis. Presentation at Australian Winter School. Brisbane, Queensland.
Klee, H. (1997). Amphetamine Misuse: International Perspectives on Current Trends. The Netherlands: Harwood Academic Publishers.
Klee, H., Wright, S., Carnwath, T. & Merrill, J. (2001). The role of substitute therapy in the treatment of problem amphetamine use. Drug and Alcohol Review, 20(4), 417-429.
Kirby, K.C., Benishek., L.A., Dugosh, K.L. & Kerwin, M.B. (2006). Substance abuse treatment providers’ beliefs and objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence, 85, 19-27.
Kolecki, P. (1998). Inadvertent methamphetamine poisoning in pediatric patients. Pediatric Emergency Care, 14, 385-387.
Krawczyk, C.S., Molitor, F., Ruiz, J., Facer, M., Allen, B., Green-Ajufo, B., Lynch, M., Klausner, C.S., McFarland, W., Bell-Sanford, G., Ferrero, D.V., Morrow, S., Page-Shafer, K. & Lemp, G. (2006). Methamphetamine use and HIV risk behaviors among heterosexual men – preliminary results from five northern California counties, December 2001-November 2003. Morbidity and Mortality Weekly Report, March 17 2006.
Lawton, BA, Taylor, R.B. & Luongo A.J. (2005). Police officers on drug corners in Philadelphia, drug crime, and violent crime: intended, diffusion, and displacement impacts. JQ: justice quarterly 22:4. 427-451.
Lee, N., Johns, L., Jenkinson, R., Johnston, J., Connolly, K., Hall, K. & Cash, R. (2007). Clinical Treatment Guidelines for Alcohol and Drug Clinicians. No 14: Methamphetamine dependence and treatment. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre Inc.
Leek, L., Seneque, D., & Ward, K. (2004). Parental drug and alcohol use as a contributing factor in care and protection applications 2003. Perth: Department for Community Development, Government of Western Australia.
Lenne, M.G. (2007). Roadside drug testing: Unanswered questions and future challenges. Drug and Alcohol Review, 26, 107-108 (Editorial).
Lineberry, T., & Bostwick, M. (2006). Methamphetamine abuse: A perfect storm of complications. Mayo Clinic Proceedings, 81, 77-84. London, E.D., Berman, S.M., Voytek, B., et al. (2005). Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biological Psychiatry, 57, 967-974.
Lough, G. (1997). Law Enforcement and harm reduction: mutually exclusive or mutually compatible? International Journal of Drug Policy. 9. 167-75.
Loxley, W., Toumbourou, J.W., Stockwell, T., Haines, B., Scott, K., Godfrey, C., Waters, E., Patton, G., Fordham, R., Gray, D., Marshall, J., Ryder, D., Saggers, S., Sanci, L. & Williams, J. (2004). The Prevention of Substance Use, Risk and Harm in Australia: A Review of the Evidence. Canberra: Commonwealth of Australia.
Luchansky, B., Krupski, A., & Stark, K. (2007). Treatment response by primary drug of abuse: Does methamphetamine make a difference? Journal of Substance Abuse Treatment, 32, 89-96.
Top of Page
Maglione, M., Chao, B. & Anglin, M.D. (2000). Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs, 32 (2), 221-228.
Maher, L., Dixon, D., Lynske, M. & Hall, W. (1998). Running the risks: Heroin, health and harm in South West Sydney. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Makkai, T. (1999). Drug Use Monitoring in Australia (DUMA): A brief description. Research and Public Policy Series, no. 21. Canberra: Australian Institute of Criminology.
Makkai, T. (2001). Statistical systems, crime statistics. In D. Featherman (Ed.), International Encyclopedia of the Social and Behavioural Sciences: Institutions and Infrastructure. Oxford: Pergamon.
Makkai, T. & McGregor, K. (2002). Drugs and crime: Calculating attributable fractions from the DUMA project. In D. Collins & H. Lapsley (Eds.), Counting the Cost: Estimates of the Social Costs of Drug Abuse in Australia in 1989-9. Canberra: Commonwealth Department of Health and Ageing.
Makkai, T. & McGregor, K. (2003). Drug Use Monitoring in Australia (DUMA): 2002 Annual Report
on Drug Use Among Police Detainees. Canberrra: Australian Institute of Criminology.
Makkai T. & Payne J (2003). Key findings from the Drug Use Careers of Offenders (DUCO) Study. Trends and Issues in Crime and Criminal Justice, No. 267.
Mattick, R. & Darke, S. (1995). Drug replacement treatments: Is amphetamine substitution a horse of a different colour? Drug and Alcohol Review, 14, 389-394.
Mausbach, B.T., Semple, S.J., Strathdee, S.A., Zians, J., & Patterson, T.L. (2007). Efficacy of a behavioural intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: Results from the EDGE study. Drug and Alcohol Dependence, 87, 249-257.
Maxwell, J.C. (2005). Emerging research on methamphetamine. Current Opinion in Psychiatry, 18, 235-242.
Mayer L, Dixon, D, Lynskey, M & Hall, W. (1998). Running the Risks: Heroin, Health and Harm in South West Sydney. Monograph No. 38. Sydney: National Drug and Alcohol research Centre, UNSW.
McCann, U.D., Mertl, M., Eligulashvili, V., & Ricaurte, G.A. (1999). Cognitive performance in
(+/-)3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) users: A controlled study. Psychopharmacology, 143, 417-425.
McDonald, J. (2003). Peer Education: From Evidence to Practice – An Alcohol and Other Drugs Primer. Adelaide: National Centre for Education on Training and Addiction.
McGregor, C., Srisurapanont, M., Jittiwutikan, J., Laobhripatr, S., Wonttan, T., & White, J.M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100, 1320-1329.
McIver, C., McGregor, C., Baigent, M., Spain, D., Newcombe, D., & Ali, R. (2006). Guidelines for the Medical Management of Patients With Methamphetamine-Induced Psychosis. South Australia: Drug and Alcohol Services South Australia.
McKetin, R., & Kelly, E. (2007). Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug and Alcohol Review, 26, 161-168.
McKetin, R., Kelly, E., Indig, D., & McLaren, J. (2004). Characteristics of treatment provided for amphetamine use in NSW, 2002-03. NDARC Technical Report No. 207. Sydney, NSW: National Drug and Alcohol Research Centre.
McKetin, R., Kelly, E., & McLaren, J. (2006). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence, 85, 198-204.
McKetin, R., & Mattick, R.P. (1997). Attention and memory in illicit amphetamine users. Drug and Alcohol Dependence, 48 (3), 235-242.
McKetin, R., McLaren, J. & Kelly, E. (2005). The Sydney Methamphetamine Market: Patterns supply, use personal harms and social consequences. National Drug Law Enforcement Research Fund. Monograph Series no. 13, Commonwealth of Australia.
McKetin, R., McLaren, J., Kelly, E., Hall, W., & Hickman, M. (2005). Estimating the number of regular and dependent methamphetamine users in Australia. National Drug and Alcohol Research Centre Technical Report no. 230, National Drug and Alcohol Research Centre, Sydney.
McKetin, R., McLaren, J., Lubman, D.I., & Hides, L. (2006a). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473-1478.
McKetin, R., McLaren, J., Riddell, S., & Robins, L. (2006b). The relationship between methamphetamine use and violent behaviour. Crime and Justice Bulletin, 97, 1-15.
Meyer, L., & Cahill, H. (2004). Principles for School Drug Education. Canberra: Australian Government Department of Education, Science and Training.
Midford, R., & Munro, G. (2006). Drug Education in Schools: Searching for the Silver Bullet. Melbourne: IP Communications.
Ministerial Council on Drug Strategy. (2004). The National Drug Strategy: Australia’s Integrated Framework 2004–2009. Commonwealth of Australia.
Ministerial Council on Drug Strategy Joint Communique (2007). National Leadership Forum on Ice – Compendium of Jurisdictional Achievements. http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mcds-16may07-communique
Minnesota Department of Health. (2002). Response to Clandestine Drug Labs. St. Paul, MN: Minnesota Department of Health, Division of Environmental Health, Site Assessment and Consultation Unit.
Molitor, F., Ruiz, J.D., Flynn, N., Mikanda, J.N., Sun, R.K., & Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse, 25 (3), 475-493.
Moore, D. (1992). Recreational Drug Use, with Particular Reference to Amphetamines, Ecstasy and LSD, Amongst a Social Network of Young People in Perth, Western Australia. Perth: National Centre for Research into the Prevention of Drug Abuse, Curtin University of Technology.
Mundy, J. (2001). Methamphetamines a growing epidemic? Connexions, April/May, 2-6.
Morgan, M.J. (2000). Ecstasy (MDMA): A review of its possible persistent psychological effects.
Psychopharmacology, 15, 230-248.
Mouzos, J., Hind, H., Smith, L. & Adams, K. (2007). Drug use monitoring in Australia 2006: Annual report on drug use among police detainees. Canberra: Australian Institute of Criminology.
Mouzos, J., Smith, L., & Hind, H. (2006). Drug use monitoring in Australia: 2005 Annual report on drug use among police detainees. Canberra: Australian Institute of Criminology.
Murray, R. A., Doering, P. L., Boothby, L. A., Merves, M. L., McCusker, R. R., Chronister, C. W. & Goldberger, B.A. (2003). Putting an ecstasy test kit to the test: Harm reduction or harm induction? Pharmacotherapy, 23(10), 1238-1244
Top of Page
National Centre for Education and Training on Addiction. (2006). Factsheet 3 – Amphetamines and Work. South Australia: NCETA, Flinders University.
National Centre in HIV Epidemiology and Clinical Research. (2007). Australian NSP Survey National Data Report 2002-2006. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.
National Drug and Alcohol Research Centre. (2003). Fact Sheet – Amphetamines. http://ndarc.med.unsw.edu.au/ndarc.nsf
National Drug Intelligence Centre. (2002). Children At Risk: Information Bulletin. Department of Justice, Washington, DC: National Drug Intelligence Center.
National Institute on Drug Abuse. (1998). Methamphetamine abuse and addiction (Research Report Series).
National Institute on Drug Abuse. (2002). Drug abuse prevention research update. NIDA Notes, 16(6). http://www.drugabuse.gov?NIDA_Notes?NNVol16N16/Conference.htm
National Leadership Forum on Ice. (2006). International and national trends, prevalence and impacts – who uses ice – what are its effects – the evidence base. Paper prepared for National Leadership Forum on Ice. Sydney: Radison Hotel.
Neaigus, A., Miller, M., Friedman, S.R., Hagen, D.L., Sifaneck, S.J., Ildefonso, G., et al. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction, 96 (6), 847-860.
New South Wales Department of Corrective Services. Compulsory Drug Treatment Correctional Centre. http://www.dcs.nsw.gov.au/offender_management/offender_management_in_ custody/correctional_centres/compdrug.asp (accessed 12 September 2007).
New South Wales Justice Health Service (2005). Our services: Drug and alcohol.
Newton, T.F, Kalechstein, A.D, Duran, S., Vansluis, N. & Ling, W. (2004). Methamphetamine abstinence syndrome: Preliminary findings. American Journal of Addiction, 13, 248-255.
Newton, T.F., Roache, J.D., De La Garza, R., Fong, T., Wallace, C.L., Li, S.H. et al. (2006). Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology, 31, 1537-1544.
Nicholas, R., & Shoobridge, J. (2005). Alcohol and other drug issues facing policing in Australia. Adelaide: Australasian Centre for Policing Research. Report produced on behalf of the Commissioners’ Drugs Committee.
Nordahl, T.E., Salo, R., & Leamon, M. (2003). Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 317-325.
NSW Health. (2005). Amphetamine, ‘Ecstasy’ and Cocaine: A Prevention and Treatment Plan 2005-2009. North Sydney, NSW: NSW Department of Health.
NSW Health (2006). Psychostimulant Users – Clinical Guidelines for Assessment and Management. North Sydney, NSW: NSW Department of Health.
Nicholas, R. (2003). The use of amphetamine type stimulants by offenders involved in high speed pursuits. A discussion paper prepared for the Commissioners’ Drugs Committee of the Conference of Police Commissioners of Australasia and the South West Pacific Region by the Australasian Centre for Policing Research.
Nicholas, R., & Shoobridge, J. (2005). Alcohol and other drug issues facing policing in Australia. Report produced on behalf of the Commissioners’ Drugs Committee, Adelaide: Australasian Centre for Policing Research.
Nurco, D., Kinlock, T. & Hanlon T. (1995). The drugs-crime connection. In J. Inciardi & K.
McElgrath (Eds.), The American Drug Scene: An Anthology. Los Angeles CA: Roxbury Publishing Co.
Nutting, A., Lee, N.K., Jenner, L. & Davies, J. (unpublished). The prevalence of mental health disorders among clients in substance use treatment. Cited in 2004 Drugs and Crime Prevention Committee (DCPC; Eds), Inquiry into Amphetamine and ‘Party Drug’ Use in Victoria: Final Report. Melbourne, Victoria: DCPC.
Top of Page
O’Brien, S., Black, E., Degenhardt, L., Roxburgh, A., Campbell, G., de Graaff, B., Fetherston, J., Jenkinson, R., Kinner, S., Moon, C., & White, N. (2007). Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Monograph No. 60. Sydney: University of New South Wales.
Palmgreen, P. & Donohew, L. (2003). Effective mass media strategies for drug abuse prevention campaigns. In Z. Sloboda & W. J. Bukoski (Eds.), Handbook of Drug Abuse Prevention: Theory, Science and Practice (p. 27-43). New York: Kluwer Academic/Plenum Publishers.
Parker, H., Bakx, K., & Newcombe, R. (1988). Living With Heroin. Milton Keyes: Open University Press.
Parliamentary Joint Committee on the Australian Crime Commission. (2007). Inquiry into the Manufacture, Importation and use of Amphetamines and Other Synthetic Drugs (AOSD). Commonwealth of Australia.
Parrott, A.C., Lees, A., Garnham, N.J., Jones, M., & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or Ecstasy – evidence for memory deficits. Journal of Psychopharmacology, 12, 79-83.
Parrott, A.C. (2006). MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Journal of Psychopharmacology, 20, 147-163.
Patton, N. (2003). Parental Drug Use – The Bigger Picture: A Review of the Literature. Melbourne: The Mirabel Foundation.
Payne, J., Kwiatkowski, M. & Wundersitz, J. (2007). Police drug diversion: a study of criminal offending outcomes. Unpublished report to the Australian Government Department of Health and Welfare (DoHA), June 2007. Canberra: Australian Institute of Criminology.
Pead, J., Lintzeris, N. & Churchill, A. (1996). From go to whoa: Amphetamines and analogues, the trainer’s package for health professionals. Canberra: Commonwealth Department of Health and Human Services, AGPS.
Penrose-Wall, J., Baume, P. & Martin, G. (1999). Achieving the Balance: A Resource Kit for Australian Media Professionals for the Reporting and Portrayal of Suicide and Mental Illnesses. Canberra: Commonwealth of Australia.
Pernanen, K., Cousineau, M., Brochu, S. & Sun, F. (2002). Proportions of crimes associated with alcohol and other drugs in Canada. Toronto: Canadian Centre on Substance Abuse.
Peroutka, S.J., Newman, H. & Harris, H. (1988). Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology, 1(4), 273-277.
Plessinger, M.A. (1998). Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North America, 25, 119-138.
Prichard, J. & Payne, J. (2005). Alcohol, drugs and crime : A study of juveniles in detention. Research and Public Policy Series, no. 67. Canberra: Australian Institute of Criminology:
Pubill, D., Canudas, A.M., Pallas, M., Camins, A., Camarasa, J. & Escubedo, E. (2003). Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedebergs Archives Pharmacology, 367, 490-499.
Putt, J., Payne J. & Milner, L. (2005). Indigenous male offending and substance abuse. Trends & Issues in Crime and Criminal Justice, No. 293. Canberra: Australian Institute of Criminology.
Top of Page
Quinlan, M. (2001). Report of Inquiry into Safety in the Long Haul Trucking Industry. Sydney, NSW: Motor Accidents Authority of New South Wales.
Ratcliffe, J. & Makkai, T. (2004): Diffusion of benefits: Evaluating a policing operation. Trends & Issues in Crime and Criminal Justice, No. 278. Canberra: Australian Institute of Criminology.
Rawson, R.A. (1999). Treatment for Stimulant Use Disorders (Treatment Improvement Protocol (TIP) Series No.33). Rockville, Maryland: US Department of Health and Human Services.
Rawson, R.A., Gonzales, R., McCann, M. & Ling, W. (2007). Use of methamphetamine by young people: Is there reason for concern? Addiction, 102 (7), 1021-1022.
Rawson, R.A., Marinelli-Casey, P., Anglin, M.D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G.P., Herrell, J., Huber, A., McCann, M.J., Obert, J., Pennell, S., Reiber, C., Vandersloot, D., Zweben, J. & the Methamphetamine Treatment Project Corporate Authors. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99. 708-717.
Reback, C.J. (1997). The Social Construction of a Gay Drug: Methamphetamine use Among Gay and Bisexual Males in Los Angeles. Los Angeles: City of Los Angeles.
Ressler, K.J., & Nemeroff, C.B. (1999). Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biological Psychiatry, 46 (9), 1219-1233.
Riley, S.C.E., James, C., Gregory, D., Dingle, H., & Cadger, M. (2001). Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction, 96 (7), 1035-1047.
Ritter, A. (2005). A review of approaches to studying illicit drug markets. Drug policy modelling project. Monograph 08. Melbourne: Turning Point Alcohol and Drug Centre.
Roche, A.M. (2007). AOD use by Australian workers: A risky mix. Of Substance, 5 (2).
Rogers, R.D., Everitt, B.J., Baldacchino, A., Blackshaw, A.J., Swainson, R., Wynne, K., Baker, N.B., Hunter, J., Carthy, T., Booker, E., London, M., Deakin, J.F., Sahakian, B.J. & Robbins, T.W. (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology, 20 (4), 322-339.
Roiser, J.P., & Sahakian, B.J. (2004). Relationship between ecstasy use and depression: A study controlling for poly-drug use. Psychopharmacology, 173 (3-4), 411-417.
Roll, J.M. (2007). Contingency management: An evidence-based component of methamphetamine use disorder treatments. Addiction, 102 (Suppl 1), 114-120.
Roll, J.M., Petry, N.M., Stitzer, M.L., Brecht, M.L., Peirce, J.M., McCann, M.J., & Blaine, J. (2006). Contingency management for the treatment of methamphetamine use disorders. American Journal of Psychiatry, 163 (11), 1993-1999.
Ross, J. (2007). Illicit Drug Use in Australia: Epidemiology, Use Patterns and Associated Harm (2nd edition). Sydney: National Drug & Alcohol Research Centre, University of New South Wales.
Roth, L. (2006). Law and order legislation in the Australian States and Territories: 2003–2006. Briefing Paper 12/2006. NSW: Parliamentary Library Research Service.
Rothman, R.B. & Baumann, M.H. (2003). Monoamine transporters and psychostimulant drugs. European Journal of Pharmacology, 479, 23-40.
Top of Page
Salo, R., Nordahl, T.E., Possin, K., Leamon, M., Gibson, D.R., Galloway, G.P., Flynn, N.M., Henik, A., Pfefferbaum, A. & Sullivan, E.V. (2002). Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research, 111, 65-74.
Sansom, D. (2001). Education and Training, National Hepatitis C Resource Manual. Melbourne: Department of Health and Aged Care and Australian Institute of Primary Care, La Trobe University.
Schifano, F. (2003). A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology, 173 (3-4), 242-248.
Schifano, F., Oyefeso, A., Corkery, J., Cobain, R., Jambert-Gray, R., Martinotti, G., & Ghodes, A.H. (2003). Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Human Psychopharmacology, 18 (7), 519-524.
Schloenhardt, A. (2007). The market for amphetamine-type stimulants and their precursors in Oceania. Research in Public Policy Series no 81 Canberra: Australian Institute of Criminology.
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., Tsuchiya, K.J., Tsukada, H., Iyo, M. & Mori, N. (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry, 63, 90-100.
Semple, S.J., Patterson, T.L., & Grant, I. (2004). The context of sexual risk behaviour among heterosexual methamphetamine users. Addictive Behaviors, 29, 807-810.
Seymour, J. (1988). Dealing With Young Offenders. Law Book Company, North Ryde, 1988.
Shearer, J. (2007). Psychosocial approaches to psychostimulant dependence: A systematic review. Journal of Substance Abuse Treatment, 32, 41-52.
Shearer, J., & Gowing, L.R. (2004). Pharmacotherapies for problematic psychostimulant use: A review of current research. Drug and Alcohol Review, 23, 203-211.
Shearer, J., Sherman, J., Wodak, A., & van Beek, I. (2002). Substitution therapy for amphetamine users. Drug and Alcohol Review, 21, 179-185.
Shearer, J., Wodak, A., Mattick, R.P., et al. (2001). Pilot randomised controlled study of dexamphetamine for amphetamine dependence. Addiction, 96, 1289-1296.
Sheridan, J., Bennett, S., Coggan, C., Wheeler, A., & McMillan, K. (2006). Injury associated with methamphetamine use: A review of the literature. Harm Reduction Journal, 3.
Shewan, D., Dalgarno, P., & Reith, G. (2000). Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy, 10, 431-453.
Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Dang, J., Roll, J., Shapiro, B., Rotheram-Fuller, E. & Ling, W. (2006). Randomised, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85, 12-18.
Shoptaw, S., & Reback, C.J. (2007). Methamphetamine use and infectious disease related behaviors in men who have sex with men: Implications for interventions. Addiction, Vol. 102 (Suppl 1), 130-135.
Shoptaw, S., Reback., C.J., Peck, J.A., Yang, X., Rotheram-Fuller, E., Larkins, S. Veniegas, R.C., Freese, T.E. & Hucks-Ortiz, C. (2005). Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78, 125-134.
Small, W., Kerr, T., Charette, J., Schechter, M.T. & Spittal, P.M. (2006). Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. International Journal of Drug Policy, 17 (2), 85-95.
Smith, H.G. (1993). Intervention strategies for children vulnerable for school failure due to exposure to drugs and alcohol. International Journal of Addiction, 28, 1435-1470.
Smith, L. (forthcoming). Amphetamine-type stimulants and violent crime. Trends & Issues in Crime and Criminal Justice. Canberra: Australian Institute of Criminology.
Smith, L., Yonekura, M.L., Wallace, T., Berman, N., Kuo, J. & Berkowitz, C. (2003). Effects of prenatal methamphetamine exposure on fetal growth and rug withdrawal symptoms in infants born at term. Journal of Developmental Behavioural Paediatrics, 24, 17-23.
Spoth, R. L., Clair, S., Shin, C., & Redmond, C. (2006). Long-term effects of universal preventive interventions on methamphetamine use among adolescents. Archives of Pediatric and Adolescent Medicine, 160, 876-882.
Spruit, I. P. (2001). Monitoring synthetic drug markets, trends, and public health. Substance Use and Misuse, 36(1-2), 23-47.
Soar, K., Turner, J.J., & Parrott, A.C. (2006). Problematic versus non-problematic ecstasy/MDMA use: The influence of drug usage patterns and pre-existing psychiatric factors. Journal of Psychopharmacology, 20 (3), 417-424.
Sommers, I., & Baskin, D. (2006). Methamphetamine use and violence. Journal of Drug Issues, 36, 77-96.
Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology, 6, 347-352.
Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2001). Treatment for amphetamine dependence and abuse. In: The Cochrane Library, Issue 4. Oxford: Update Software.
Srisurapanont, M., Sombatmai, S., & Boripuntakul, T. (2007). Brief Intervention for students with methamphetamine use disorders: A randomized controlled trial. American Journal on Addictions, 16, 111-116.
Steering Committee for the Review of Government Service Provision. (2006). Report on Government Services. Melbourne: Productivity Commission.
Strang, J., Des Jarlais, D.C., Griffiths, P., & Gossop, M. (1992). The study of transitions in the route of drug use: The route from one route to another. British Journal of Addiction, 87, 473-483.
Stubbs, M., Hides, L., Howard, J., & Arcuri, A. (2004). Psychostimulants and young people. In A. Baker, N.K. Lee, & L. Jenner (Eds), Models of Intervention and Care for Psychostimulant Users (2nd Edition). National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
Substance Abuse and Mental Health Services Administration. (2003). Substance abuse prevention programs reduce high-risk youth drug use. http://www.stopgettingsick.com/
Sumnall, H.R., & Cole, J.C. (2005). Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: A meta-analysis. Journal of Psychopharmacology, 19 (1), 84-92.
Top of Page
Tancer, M.E. & Johanson, C.E. (2001). The subjective effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence, 65(1), 97-101.
Taylor, W.A., & Gold, M.S. (1990). Pharmacologic approaches to the treatment of cocaine dependence. Western Journal of Medicine, 152, 573-577.
Ted Noffs Foundation. PALM Program. http://www.noffs.org.au/programs/palm.shtm.
Thomasius, R., Zapletalova, P., Petersen, K. et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: The longitudinal perspective. Journal of Psychopharmacology, 20, 211-225.
Thompson, P.M., Hayashi, K.M., Simon, S.L. et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24, 6028-6036.
Tiihonen, J., Kuoppasalmi, K., Fohr, J., Tuomola, P., Kuikanmaki, O., Vorma, H., Sokero, P., Haukka, J., & Meririnne, E. (2007). A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. The American Journal of Psychiatry, 164 (1), 160162.
Topp, L., Degenhardt, L., Kaye, S. & Darke, S. (2002). The emergence of potent forms of methamphetamine in Sydney, Australia: A case study of the IDRS as a strategic early warning system. Drug and Alcohol Review, 21 (4), 341-348.
Trewin, D. (2006a). National Aboriginal and Torres Strait Islander Health Survey 2004-05. ABS Catalogue No. 4715.0. Canberra: Australian Bureau of Statistics, Commonwealth of Australia.
Trewin, D. (2006b). 2006 Prisoners in Australia. Australian Bureau of Statistics, Catalogue No. 5417.0. Canberra: Australian Bureau of Statistics, Commonwealth of Australia.
Turner, J.J.D & Parrot, A.C. (2000). ‘Is MDMA a human neurotoxin: Diverse views from the discussants. Neuropsychobiology, 42, 42-48.
Turnipseed, S., Richards, J., Kirk, J, et al. (2003). Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. Journal of Emergency Medicine, 24, 369-373.
Tyler, A. (1986). Street Drugs. Great Britain: Hodder & Stoughton.
Tzschentke, T.M. (2001). Pharmacology and behavioural pharmacology of the mesocortical dopamine system. Progress in Neurobiology, 63 (3), 241-320.
United Nations Drug Control Programme. (1996). Amphetamine-Type Stimulants: A Global Review. Vienna: UNDCP/TS6.
United Nations Office for Drug Control and Crime Prevention. (2001). World Drug Report 2000. Oxford: Oxford University Press.
United Nations Office on Drugs and Crime. (2006). 2006 World Drug Report. Vienna: United Nations Office on Drugs and Crime.
United Nations Office on Drugs and Crime. (2007). 2007 World Drug Report. Vienna: United Nations Office on Drugs and Crime. van de Wijngaart, G. F., Braam, R., de Bruin, D., Fris, M., Maalste, N. J. M., & Verbraeck, H.
T. (1999). Ecstasy use at large-scale dance events in the Netherlands. Journal of Drug Issues, 29(3), 679-702.
Top of Page
Vincent, N., Shoobridge, J., Ask, A., Allsop, S. & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide. South Australia: South Australia National Centre for Education and Training on Addiction, Flinders University.
VIVAIDS. (2005). RaveSafe Survey. In collaboration with the Centre for Youth Drug Studies. Melbourne, Victoria.
Vocci, F.J. & Appel, N.M. (2007). Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction, 102 (Suppl 1), 96-106.
Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M., et al. (2001). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21, 9414-9418.
Weatherburn, D, & Lind, B. (1999). Heroin harm minimisation: Do we really have to choose between law enforcement and treatment? Crime and Justice Bulletin, No. 46. Sydney: NSW Bureau of Crime Statistics and Research.
Weatherburn, D., Lind, B. & Forsythe L. (1999). Drug Law Enforcement: Its effect on Treatment and Injection Practices. Sydney: NSW Bureau of Crime Statistics and Research.
Weatherburn, D., Jones, C., Freeman, K. & Makkai, T. (2003). Supply control and harm reduction: Lessons from the Australian heroin ‘drought’. Addiction, 98, 83-91.
Weisburd, D., Wyckoff, L.A., Ready, J., Eck, J.E., Hinkle, J.C. & Gajewski, F. (2006). Does crime just move around the corner? A controlled study of spatial displacement and diffusion of crime control benefits. Criminology, 44 (3), 549-591.
White, P., Chant, D., Whiteford, H. (2006). A comparison of Australian men with psychotic disorders remanded for criminal offences and a community group of psychotic men who have not offended. Australian and New Zealand Journal of Psychiatry, 40, 260-265.
White, R. (2000). Dexamphetamine substitution in the treatment of amphetamine abuse: An initial investigation. Addiction, 95 (2), 229-238.
White, V., & Hayman, J. (2006). Australian secondary school students’ use of over the-counter and illicit substances in 2005. National Drug Strategy.
Wilczynski, A. & Pigott, R. (2004). The relationship between drugs and crime. Australia. AttorneyGeneral’s Department.
Wilkins, C., Pledger, M., Lee, A., Adams, R. & Rose, E. (2004). A local pilot of the New Zealand Arrestee Drug Abuse Monitoring (NZ-ADAM) System. Auckland: Massey University.
Willens, T.E., Biederman, J., Kiely, K., Bredin, E., Lic, S.W., & Spencer, T.J. (1995). Pilot study of behavioural and emotional disturbances in the high-risk children of parents with opioid dependence. Journal of American Academy of Child Adolescent Psychiatry, 34, 779-785.
Williamson, A., Colley, M., Hayes, L. & O’Neill, L. (2006). Final report of stimulant use by long distance road transport drivers project. NSW Injury Risk Management Research Centre, University of New South Wales, Injury Risk Management Research Centre.
Winstock, A.R., Wolff, K., & Ramsey, J. (2001). Ecstasy pill testing: Harm minimisation gone too far? Addiction, 96 (8), 1139-1148.
World Health Organisation. (1997). Amphetamine-Type Stimulants: A report from the WHO Meeting on Amphetamines, MDMA and other Psychostimulants. Geneva, 12-15
November 1996. Geneva: Division of Mental Health and Prevention of Substance Abuse, World Health Organisation.
Worth, H. & Rawstorne, P. (2005). Crystallising the HIV epidemic: Methamphetamine, unsafe sex, and gay diseases of the will. Archives of Sexual Behaviour, 34, 483-486.
Wright, S., & Klee, H. (2001). Violent crime, aggression and amphetamine: What are the implications for drug treatment services? Drugs: Education, Prevention and Policy, 8, 7390.
Wright, S., Klee, H., & Reid, P. (1999). Attitudes of amphetamine users towards treatment services. Drugs: Education, Prevention, and Policy, 6, 71-86.
Zablotska, I., Prestage,G., Hull, P., Crawford, J., Kippax, S., Sutherland, R., Corrigan, N. & Honnor, G. (2006). Sydney Gay Community Periodic Survey, February 1996 to February 2006. National Centre in HIV Social Research, National Centre in HIV Epidemiology and Clinical Research and The University of New South Wales, National Centre in HIV Social Research.
Zule, W. & Desmond, D. (1999). An ethnographic comparison of HIV risk behaviours among heroin and methamphetamine injectors. American Journal of Drug and Alcohol Abuse, 25(1), 1-22.
Zweben, J.E., Cohen, J.B., Christian, D., Galloway, G.P., Salinardi, M., Parent, D. & Iguchi, M for the Methamphetamine Treatment Project. (2004). Methamphetamine Treatment Project. Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13, 181-190.
